| Literature DB >> 29069598 |
Andrea Giorgi1, Sara Migliarini2, Alberto Galbusera3, Giacomo Maddaloni2, Maddalena Mereu4, Giulia Margiani4, Marta Gritti5, Silvia Landi6, Francesco Trovato6, Sine Mandrup Bertozzi7, Andrea Armirotti7, Gian Michele Ratto6, Maria Antonietta De Luca4, Raffaella Tonini5, Alessandro Gozzi8, Massimo Pasqualetti1.
Abstract
Serotonin-producing neurons profusely innervate brain regions via long-range projections. However, it remains unclear whether and how endogenous serotonergic transmission specifically influences regional or global functional activity. We combined designed receptors exclusively activated by designed drugs (DREADD)-based chemogenetics and functional magnetic resonance imaging (fMRI), an approach we term "chemo-fMRI," to causally probe the brain-wide substrates modulated by endogenous serotonergic activity. We describe the generation of a conditional knockin mouse line that, crossed with serotonin-specific Cre-recombinase mice, allowed us to remotely stimulate serotonergic neurons during fMRI scans. We show that endogenous stimulation of serotonin-producing neurons does not affect global brain activity but results in region-specific activation of a set of primary target regions encompassing corticohippocampal and ventrostriatal areas. By contrast, pharmacological boosting of serotonin levels produced widespread fMRI deactivation, plausibly reflecting the mixed contribution of central and perivascular constrictive effects. Our results identify the primary functional targets of endogenous serotonergic stimulation and establish causation between activation of serotonergic neurons and regional fMRI signals.Entities:
Keywords: CBV; CNO; DREADD; citalopram; clozapine; connectivity; dopamine; pharmacokinetics
Mesh:
Substances:
Year: 2017 PMID: 29069598 DOI: 10.1016/j.celrep.2017.09.087
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423